An internal review published by the U.S. Food and Drug Administration (FDA) on Tuesday found that multiple factors hindered the agency’s response this year to the nationwide shortage of baby formula.
Steven Solomon, the head of the FDA’s veterinary division who conducted the internal review, said he found five “major areas of need” and 15 specific findings, and provided recommendations to improve the agency’s infant formula regulation and oversight.
